Geron Corp. is set to receive $25 million from the California Institute for Regenerative Medicine to support the clinical work on its stem-cell therapy for spinal cord injury. The money is a loan with repayment contingent on product success. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
